Clinica Baviera SA
SWB:D9Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinica Baviera SA
SWB:D9Z
|
ES |
|
J
|
Johnson Electric Holdings Ltd
SWB:JOHB
|
HK |
|
American Copper Development Corp
OTC:ACDXD
|
CA |
|
Bank BTPN Syariah Tbk PT
IDX:BTPS
|
ID |
|
B
|
Base Carbon Inc
OTC:BCBNF
|
CA |
|
Retailors Ltd
OTC:RTALF
|
IL |
Wall St Price Targets
D9Z Price Targets Summary
Clinica Baviera SA
According to Wall Street analysts, the average 1-year price target for D9Z is 70.98 EUR with a low forecast of 70.28 EUR and a high forecast of 73.07 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is D9Z's stock price target?
Price Target
70.98
EUR
According to Wall Street analysts, the average 1-year price target for D9Z is 70.98 EUR with a low forecast of 70.28 EUR and a high forecast of 73.07 EUR.
What is the Revenue forecast for Clinica Baviera SA?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Clinica Baviera SA?
Projected CAGR
-15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is -15%.
What is the Operating Income forecast for Clinica Baviera SA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 3 years is 12%.
What is the Pre-Tax Income forecast for Clinica Baviera SA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 55%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Clinica Baviera SA?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 3 years is 14%.
